PITTSBURGH, Oct. 16 /PRNewswire/ -- invivodata, inc., the industry leader in patient reported outcomes (PRO) solutions and consulting services for global clinical research, today announced a series of featured presentations and exhibits at upcoming industry events by representatives from invivodata and its scientific and regulatory consulting division, PRO Consulting®.

Scientific, regulatory, and technical experts from invivodata and PRO Consulting will share their knowledge on the collection of PRO data and e-clinical technologies at the following industry events:

    --  ePROficiency(TM) 2009 Webinar Series (Oct. 22, 2009).  "Supporting
        Regulatory Submissions and Inspections: the ePRO Perspective." This
        webinar will review the key areas of focus for ePRO submissions and
        inspections from the site, the sponsor, and the ePRO partner
        perspective.
        (http://www.patientreported.com/news-events/index.cfm?i=1845)
    --  International Society for Pharmacoeconomics and Outcomes Research
        (ISPOR) Annual European Congress (Oct. 24-27, 2009 in Paris, France). 
        PRO Consulting scientists will be available to meet with researchers at
        the PRO Consulting exhibit booth.
    --  Measuring Study Endpoints in Multinational Clinical Trials: Outcomes
        Reported from the Viewpoint of the Clinician, Patient, and Caregiver
        (Oct. 26-27, 2009 in New Orleans, LA).  Dr. Katarina Halling will
        present, "Industry Best Practice for Instrument Modifications" at this
        Drug Information Association (DIA) event.
    --  PRO Consulting Networking Reception (Oct. 27, 2009 in New Orleans, LA). 
        PRO Consulting is hosting a networking reception with complimentary
        food, drinks, jazz music and entertainment.  Registration for this event
        can be found at www.patientreported.com/neworleans.
    --  International Society for Quality of Life Research (ISOQOL) 16th Annual
        Conference (Oct. 28-31, 2009, in New Orleans, LA).   PRO Consulting
        representatives will present the following posters:
        --  "Using 'Overall' versus 'At its Worst' to Frame Assessment of
            Symptom Concepts:  Patient Input from Cognitive Interviews" (Dr.
            Alan Shields).
        --  "Considerations when Translating ePRO Measures for use on an
            Electronic Platform" (Celeste Elash).
        --  "Enhancing Content Validity in Patient Reported Outcomes: Using
            Patient Input to Focus Concept Measurement" (Dr. Alan Shields).
    --  CBI's 5th Patient Reported Outcomes Conference (Nov. 17-18, 2009 in
        Philadelphia, PA).  PRO Consulting scientists are leading the following
        sessions:
        --  Dr. Alan Shields and Dr. Ashley Slagle will lead a workshop
            entitled, "Explore the Key Areas of a PRO Dossier that Demonstrate
            if an Instrument Is Fit for Purpose".

        --  Dr. Jean Paty will present, "Marketing insight vs. Instrument
            Development Patient Interviews:  Are they really different?"

Pharmaceutical researchers who want to stay current on regulatory and industry trends related to PROs can do so via invivodata's ePRO Resource Center at http://www.invivodata.com/epro-resources/. Here, clinical researchers can find relevant and practical information, including complimentary access to recordings of previously conducted Webinars and recent publications, such as a White Paper released last month describing the important factors sponsors should consider when deciding between device-based and Interactive Voice Response (IVR)-based ePRO technology for their clinical trials.

About invivodata, inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, web-based access to study data and operational reports that give researchers and sponsors visibility into study progress, and scientific and regulatory consulting on the use of PRO data in a regulated environment. invivodata's solution has been used in more than 275 clinical programs and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata, inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters are in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit www.invivodata.com.

About PRO Consulting

PRO Consulting, a division of invivodata, inc., provides consulting services to help clinical research teams effectively develop, execute, and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has more than 140 years of cumulative experience in psychometrics, PRO study design, migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies. For more information please visit http://www.patientreported.com.

    For more information, contact:

    Invivodata, inc.
    Christine Tobin
    Corporate Communications Specialist
    (412) 390-3000, ext. 3502
    ctobin@invivodata.com

SOURCE invivodata, inc.